The Clinical Treatment Score post-5-years tool helps clinicians identify which patients are at high risk of their cancers recurring after completing five years of adjuvant hormone therapy.
Clew Medical aggregates data from multiple devices and information systems to identify and refine patterns that indicate patient deterioration.
